Dolby Laboratories, Inc. (NYSE:DLB) Q4 2023 Earnings Call Transcript November 16, 2023 5:00 PM ET Company Participants Peter Goldmacher - VP of IR Kevin Yeaman - CEO Robert Park - CFO Conference Call Participants Steven Frankel - Rosenblatt Securities Ralph Schackart - William Blair James Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by, and welcome to the Dolby Laboratories Conference Call discussing Fiscal Fourth Quarter Results. During the presentation, all participants ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 29, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or other ju ...

Dolby Laboratories, Inc. (NYSE:DLB) Q3 2023 Earnings Conference Call August 3, 2023 5:00 PM ET Company Participants Liz Krukowski - Vice President, Communications & People Experience Kevin Yeaman - Chief Executive Officer Robert Park - Chief Financial Officer Conference Call Participants Ralph Schackart - William Blair Steven Frankel - Rosenblatt Securities Jim Goss – Barrington Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories' Conference Call discussing F ...

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 OR Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or other ...

Dolby Laboratories, Inc. (NYSE:DLB) Q2 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Maggie O’Donnell – Head-Investor Relations Kevin Yeaman – Chief Executive Officer Robert Park – Chief Financial Officer Conference Call Participants Steven Frankel – Rosenblatt Paul Chung – JPMorgan Ralph Schackart – William Blair James Goss – Barrington Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories’ Conference Call discussing fiscal second q ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or othe ...

Dolby Laboratories, Inc. (NYSE:DLB) Q1 2023 Earnings Conference Call February 2, 2023 5:00 PM ET Company Participants Maggie O'Donnell - Head of Investor Relations Kevin Yeaman - Chief Executive Officer Robert Park - Chief Financial Officer Conference Call Participants Steven Frankel - Rosenblatt Paul Chung - J.P. Morgan Ralph Schackart - William Blair Jim Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fiscal ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or o ...

Dolby Laboratories, Inc. (NYSE:DLB) Q4 2022 Earnings Conference Call November 17, 2022 5:00 PM ET Company Participants Ashley Schwenoha - Senior Manager, IR Maggie O'Donnell - Head, IR Kevin Yeaman - President and CEO Robert Park - SVP and CFO Conference Call Participants Ralph Schackart - William Blair & Company L.L.C., Research Division Steven Frankel - Rosenblatt Securities Inc., Research Division Paul Chung - JPMorgan Chase & Co, Research Division Jim Goss - Barrington Research Associates, Inc., Researc ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or other ju ...